Serum creatinine to cystatin C ratio as monitoring biomarker in Chinese adult spinal muscular atrophy: a prospective cohort study
Abstract Background The creatinine to cystatin C ratio (CCR) can be used as a biomarker of muscle mass and strength, but no studies have evaluated whether it can be used as a biomarker to monitor the efficacy of treatment with nusinersen in Chinese adults with 5q-associated spinal muscular atrophy (...
Saved in:
| Main Authors: | Sihui Chen, Qiong Wang, Jiajia Fu, Qianqian Wei, Ruwei Ou, Xiaohui Lai, Xueping Chen, Huifang Shang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-025-03730-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A cross-sectional and longitudinal evaluation of serum creatinine as a biomarker in spinal muscular atrophy
by: Xin Zhao, et al.
Published: (2024-12-01) -
Experience of Nusinersen in children with proximal spinal muscular atrophy 5q in Moscow region
by: M. V. Panteleeva
Published: (2022-12-01) -
Common complications in spinal muscular atrophy (SMA) type 1 after nusinersen treatment
by: Yiğithan Güzin, et al.
Published: (2024-11-01) -
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Australian Hospitals
by: Ian R. Woodcock, et al.
Published: (2025-04-01) -
Experience with nusinersen as a pathogenetic therapy in adult patients with spinal muscular atrophy 5q in the Republic of Bashkortostan
by: S. V. Umutbaev, et al.
Published: (2023-03-01)